134 related articles for article (PubMed ID: 3517510)
21. Studies on macrophage-activating factor (MAF) in antitumor immune responses. I. Tumor-specific Lyt-1+2- T cells are required for producing MAF able to generate cytolytic as well as cytostatic macrophages.
Nakajima H; Fujiwara H; Takai Y; Izumi Y; Sano S; Tsuchida T; Hamaoka T
J Immunol; 1985 Sep; 135(3):2199-205. PubMed ID: 3894520
[TBL] [Abstract][Full Text] [Related]
22. Enhancement of macrophage Fc-dependent phagocytosis by resident thymocytes: effect of a unique heat-stable lymphokine.
Coleman DL; Root RK; Ryan JL
J Immunol; 1983 May; 130(5):2195-9. PubMed ID: 6339624
[TBL] [Abstract][Full Text] [Related]
23. Macrophage activation to kill Leishmania tropica: characterization of P/J mouse macrophage defects for lymphokine-induced antimicrobial activities against Leishmania tropica amastigotes.
Nacy CA; Meltzer MS; Fortier AH
J Immunol; 1984 Dec; 133(6):3344-50. PubMed ID: 6491291
[TBL] [Abstract][Full Text] [Related]
24. In vitro induction of tumoricidal and suppressor macrophages by lymphokines: possible feedback regulation.
Taramelli D; Holden HT; Varesio L
J Immunol; 1981 Jun; 126(6):2123-8. PubMed ID: 6453155
[TBL] [Abstract][Full Text] [Related]
25. Differences in antibody-dependent cellular cytotoxicity and activated killing of tumor cells by macrophage cell lines.
Ralph P; Nakoinz I
Cancer Res; 1981 Sep; 41(9 Pt 1):3546-50. PubMed ID: 6973392
[TBL] [Abstract][Full Text] [Related]
26. Recombinant mouse gamma interferon induces the priming step in macrophage activation for tumor cell killing.
Pace JL; Russell SW; Torres BA; Johnson HM; Gray PW
J Immunol; 1983 May; 130(5):2011-3. PubMed ID: 6403616
[TBL] [Abstract][Full Text] [Related]
27. Mechanism of macrophage-mediated cytotoxicity: production of a soluble cytotoxic factor.
Drysdale BE; Zacharchuk CM; Shin HS
J Immunol; 1983 Nov; 131(5):2362-7. PubMed ID: 6415164
[TBL] [Abstract][Full Text] [Related]
28. Generation of alloreactive cytotoxic T lymphocytes: production of T cell and macrophage helper factors in addition to IL 1 and IL 2 by peritoneal cells from mice immunized to Listeria monocytogenes.
Finke JH; Sharma SD; Scott JW
J Immunol; 1981 Dec; 127(6):2354-61. PubMed ID: 6795272
[TBL] [Abstract][Full Text] [Related]
29. Lymphokine-induced cytotoxicity: requirement of two lymphokines for the induction of optimal cytotoxic response.
Yang SS; Malek TR; Hargrove ME; Ting CC
J Immunol; 1985 Jun; 134(6):3912-9. PubMed ID: 3921614
[TBL] [Abstract][Full Text] [Related]
30. Macrophage activation: synergism between hybridoma MAF and poly(I). Poly(C) delivered by liposomes.
Pidgeon C; Schreiber RD; Schultz RM
J Immunol; 1983 Jul; 131(1):311-4. PubMed ID: 6408176
[TBL] [Abstract][Full Text] [Related]
31. The role of plasma membrane receptors and the kinetics of macrophage activation by lymphokines encapsulated in liposomes.
Fidler IJ; Raz A; Fogler WE; Hoyer LC; Poste G
Cancer Res; 1981 Feb; 41(2):495-504. PubMed ID: 7004633
[TBL] [Abstract][Full Text] [Related]
32. Intracellular destruction of Leishmania tropica by macrophages activated with macrophage activating factor/interferon.
Titus RG; Kelso A; Louis JA
Clin Exp Immunol; 1984 Jan; 55(1):157-65. PubMed ID: 6198115
[TBL] [Abstract][Full Text] [Related]
33. In vitro kinetics of functional parameters of macrophage activation with lymphokines and its relation to tumor cell cytostasis.
Matsunaga K; Mashiba H
Jpn J Exp Med; 1981 Oct; 51(5):287-92. PubMed ID: 7321254
[TBL] [Abstract][Full Text] [Related]
34. Intracellular replication and lymphokine-induced destruction of Leishmania tropica in C3H/HeN mouse macrophages.
Nacy CA; Meltzer MS; Leonard EJ; Wyler DJ
J Immunol; 1981 Dec; 127(6):2381-6. PubMed ID: 7299130
[TBL] [Abstract][Full Text] [Related]
35. Macrophages in resistance to rickettsial infections: characterization of lymphokines that induce rickettsiacidal activity in macrophages.
Nacy CA; Leonard EJ; Meltzer MS
J Immunol; 1981 Jan; 126(1):204-7. PubMed ID: 7005333
[TBL] [Abstract][Full Text] [Related]
36. Activation of mouse macrophages for tumor cell killing. I. Quantitative analysis of interactions between lymphokine and lipopolysaccharide.
Pace JL; Russell SW
J Immunol; 1981 May; 126(5):1863-7. PubMed ID: 7217671
[TBL] [Abstract][Full Text] [Related]
37. Binding of calmodulin to the microfilament network correlates with induction of a macrophage tumoricidal response.
Mecham JO; Soong MM; Cain CA; Koehm S; Goff J; Tompkins WA
J Immunol; 1985 May; 134(5):3516-23. PubMed ID: 3884713
[TBL] [Abstract][Full Text] [Related]
38. Suppression of T-cell mediated lymphokine production but not cytotoxic activity by macrophages.
Varesio L; Eva A; Cavallo G; Herberman RB
Boll Ist Sieroter Milan; 1980 Mar; 59(1):12-6. PubMed ID: 6970038
[TBL] [Abstract][Full Text] [Related]
39. Phenotypic characterization of human T lymphocyte populations producing macrophage-activating factor (MAF) lymphokines.
Biondi A; Roach JA; Schlossman SF; Todd RF
J Immunol; 1984 Jul; 133(1):281-5. PubMed ID: 6373929
[TBL] [Abstract][Full Text] [Related]
40. Dissociation between macrophage tumoricidal capacity and suppressive activity: analysis with macrophage-defective mouse strains.
Boraschi D; Pasqualetto E; Ghezzi P; Salmona M; Bartalini M; Barbarulli G; Censini S; Soldateschi D; Tagliabue A
J Immunol; 1983 Oct; 131(4):1707-13. PubMed ID: 6311895
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
